Home/Pipeline/24-valent Pneumococcal Conjugate Vaccine

24-valent Pneumococcal Conjugate Vaccine

Pneumococcal Disease Prevention

Pre-clinicalActive

Key Facts

Indication

Pneumococcal Disease Prevention

Phase

Pre-clinical

Status

Active

Company

A leading Chinese vaccine developer leveraging adenovirus vector technology to create innovative vaccines for global infectious disease prevention.

Drug	Company	Phase	Status
13-valent Pneumococcal Conjugate Vaccine (PCV13)	Hualan Biological Engineering	Phase III	Active
23-valent Pneumococcal Polysaccharide Vaccine	AB & B Biotech	Phase 1	Active
Pneumococcal Polysaccharide Vaccine (PPV)	Sinovac Biotech	Phase II	Active